Thermo Fisher Scientific Expands its Global Biologics and Steriles Manufacturing Capabilities in China
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
Stalled deliveries of clinical supplies to global investigator sites have the potential to derail trials and put study patients at risk. Clinical Trial Insight talks to Ian Hunter, commercial director of logistics at Fisher Clinical Services, about the company’s strategy for minimizing delays to ensure clinical supplies reach the sites and patients who need them on time.